Early data on an oral semaglutide show daily dosing can achieve about 15% weight loss (versus 23% on placebo), suggesting pill-based GLP-1 therapy can match injections if absorbed properly
The benefits of Mounjaro include: Improved control of diabetes symptoms Improved blood sugar levels Increased glycemic control Weight loss However, you should not take Mounjaro if: You are breastfeeding You are pregnant You have a family history of medullary thyroid carcinoma (MTC) You have a family history of multiple endocrine neoplasia syndrome type 2 (MEN2) You have had MTC You have had pancreatitis You plan to become pregnant in the next three months Mounjaro can negatively impact some oral contraceptives
45(Suppl 1): S144S174
Improper reporting can give you false confidence in your food choices and can ultimately lead to acute kidney injury, heart disease, acute gallbladder disease, and more
The current understanding points to a potential biphasic pattern in GLP-1 RA studies, where any observed early worsening may be related to rapid glycemic improvement rather than direct retinal toxicity, particularly in patients with pre-existing retinopathy, poor glycemic control, and those undergoing HbA1c reduction 47
And listen, if it's right for you, I can't wait to see you in there
